Evidence map›Paper›PMID 39942640›Full record

ArticleMolecules (Basel, Switzerland)2025

Effectively Enhanced Photocatalytic Performance of BP/BiOBr 2D/2D Z-Scheme Heterojunction.

Jian Feng, Xia Ran, Li Wang, Bo Xiao, Jinming Zhu, Zuoji Liu, Chaozhong Li, Rong Li, Guangwei Feng, Ke Xu

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jian FengSchool of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, China.ORCID 0000-0002-1404-2354
Xia RanSchool of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, China.
Li WangSchool of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, China.
Bo XiaoSchool of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, China.ORCID 0009-0007-0638-9087
Jinming ZhuSchool of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, China.
Zuoji LiuSchool of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, China.
Chaozhong LiSchool of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, China.
Rong LiSchool of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, China.
Guangwei FengSchool of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, China.
Ke XuSchool of Chemistry and Materials Science, Guizhou Education University, 115 Gaoxin Road, Guiyang 550018, China.

Funding

Guizhou Provincial Science and Technology Project, China ZK[2023]290Key Project of Basic Research Program of Guizhou Province, China ZK[2021]022
6 · The paper itself

Abstract

Black phosphorus (BP) is a novel two-dimensional (2D) material with remarkable potential for use in environmental remediation and energy conversion. However, the practical application of BP is significantly limited by its low catalytic efficiency and poor structural stability. In this study, a Z-scheme BP/BiOBr 2D/2D heterojunction was fabricated using a simple solution reaction method at room temperature. The BP/BiOBr heterojunction exhibited significantly enhanced photocatalytic performance in the degradation of various organic pollutants and the production of hydrogen under visible light irradiation. This improved activity can be attributed to the efficient separation of photogenerated charges and the extended lifetime of charge carriers within the heterojunction. The durability and structural stability of the BiP-10 heterojunction were demonstrated through cycling tests, which maintained high photocatalytic efficiency over multiple uses. This study presents a promising approach to the development of BP-based photocatalytic materials for sustainable environmental and energy applications.

Indexed as

BP/BiOBrciprofloxacinhydrogen evolutionZ-scheme

Identifiers

PMID39942640
PMCPMC11820221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.